5000th patient treated with protons for eye tumours
From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue. © HZB/. S. Kodalle
The treatment centre for eye tumour therapy in Berlin-Wannsee © HZB/ S. Kodalle
For more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.
The treatment room and proton accelerator are specially adapted to the requirements for optimal and highly precise treatment of tumours inside the eye and are unique in this combination. The largest group of tumours in the eye is the rare and malignant uveal melanoma, which, as the name suggests, develops in the uvea of the eye.
Proton therapy is used as an effective method of fighting tumours, often as an alternative to removing the eye, with the aim of preserving the eye and its function as much as possible. The protons can be directed very precisely at the tumour, sparing the surrounding healthy tissue. Compared to other radiation methods, proton therapy causes less damage to the cornea, lens, retina and optic nerve in many cases.
8 August 2025 was a special day: it was the day on which the 5000th patient completed their eye tumour treatment. This makes the Berlin experts one of the world's leading centres: together, the two institutions (Charité and HZB) have treated 10 percent of all eye tumours treated with protons worldwide. The cooperation with Charité – Universitätsmedizin Berlin also opens up prospects for the further development of proton therapy in order to carry out even more precise and effective treatments in the future – for the benefit of patients.
- A New Era in Catalysis: ASCEND Launch in Berlin, €30 Million in FundingOn 11 June 2026, the Helmholtz-Zentrum Berlin (HZB) in Adlershof hosted the launch of ASCEND (Accelerated Solutions for Catalysis using Emerging Nanotechnology and Digital Innovation). The event took place in the presence of the Minister of Research, Dorothee Bär, President of the Helmholtz Association, Prof. Dr. Martin Keller, and President of the Max Planck Society, Prof. Dr. Patrick Cramer. Bringing together leading partners from industry and research, ASCEND is supported by BMFTR with €30 million in funding and officially started on 1 April 2026. The initiative aims to accelerate the discovery of next-generation catalysts and enable more sustainable chemical processes.
- X-ray analysis reveals overpainted fascist symbolsErich Mercker was a successful painter during the Nazi era and in the years that followed. After 1945, he covered up Nazi symbols in at least one of his paintings. With an interdisciplinary team, physicist Dr Ioanna Mantouvalou reports on this study in the Nature Journal Heritage Science.
- Magnon momentum microscopy: A new window into nanoscale spin-wavesAn international team lead by the Max Born Institute has developed a new type of momentum microscopy to image magnons — the quanta of collectively excited spins — directly in two-dimensional reciprocal space using soft X-rays. Measurements have taken place at BESSY II and PETRA III, first author ist the HZB physicist Steffen Wittrock. Owing to its remarkable sensitivity, simplicity, and access to nanometer-scale wavelengths, this novel technique establishes a powerful and versatile platform for exploring nonlinear magnon interactions, which are promising for future computing schemes.